Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
IsraelIPO:
28 June 2018Website:
http://www.enterabio.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 26 Jun 2024 22:55:15 GMTDividend
Analysts recommendations
Institutional Ownership
ENTX Latest News
Entera Bio Ltd. (ENTX) closed at $1.98 on the most recent trading day, reflecting a 1% decrease from the previous closing price.
At the end of the most recent trading day, Entera Bio Ltd. (ENTX) closed at $2.24, reflecting a 0.9% increase from the previous day's closing price.
Here is the performance comparison of Entera Bio Ltd. (ENTX) and FibroGen (FGEN) relative to their sector year to date.
In this article, we explore why purchasing Entera Bio (ENTX) stock at this time could be a wise decision.
Entera Bio Ltd. (ENTX) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.12.
Entera Bio Ltd. (ENTX) delivered earnings and revenue surprises of 16.67% and 86%, respectively, for the quarter ended December 2022.
What type of business is Entera Bio?
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.
What sector is Entera Bio in?
Entera Bio is in the Healthcare sector
What industry is Entera Bio in?
Entera Bio is in the Biotechnology industry
What country is Entera Bio from?
Entera Bio is headquartered in Israel
When did Entera Bio go public?
Entera Bio initial public offering (IPO) was on 28 June 2018
What is Entera Bio website?
https://www.enterabio.com
Is Entera Bio in the S&P 500?
No, Entera Bio is not included in the S&P 500 index
Is Entera Bio in the NASDAQ 100?
No, Entera Bio is not included in the NASDAQ 100 index
Is Entera Bio in the Dow Jones?
No, Entera Bio is not included in the Dow Jones index
When does Entera Bio report earnings?
The next expected earnings date for Entera Bio is 09 August 2024